Long-acting growth hormone-releasing peptide
CJC-1295
A longer-acting growth hormone-releasing peptide often discussed alongside secretagogues like Ipamorelin in performance and recovery programs.
Overview
CJC-1295 is designed to extend the signaling window compared to shorter-acting growth hormone-releasing peptides. It's frequently offered in combination protocols, and programs vary in how they structure monitoring and follow-up.
